Nuzenio

Insilico Medicine Receives

Insilico Medicine Receives news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer - news-medical.netnews-medical.net · Tue, 04 Aug 2026 16:02:00 GMTInSilico Medicine Cayman TopCo Receives NMPA IND Approval for ISM8969/HT-001, Blood-Brain-Barrier-Penetrant NLRP3 Inhibitor Co-Developed with Hygtia Therapeutics Co., Ltd - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 05:21:39 GMTInsilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma - Insilico MedicineInsilico Medicine · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Tue, 04 Aug 2026 16:02:00 GMTInsilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer - news-medical.net
Mon, 03 Aug 2026 05:21:39 GMTInSilico Medicine Cayman TopCo Receives NMPA IND Approval for ISM8969/HT-001, Blood-Brain-Barrier-Penetrant NLRP3 Inhibitor Co-Developed with Hygtia Therapeutics Co., Ltd - marketscreener.com
Tue, 28 Jul 2026 07:00:00 GMTInsilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma - Insilico Medicine

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Insilico Medicine Receives.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.